Litcius/Paper detail

Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria

Hani Amir Aouissi, Mostefa Ababsa, Aissam Gaagai

2021Bulletin of the National Research Centre/Bulletin of the National Research Center13 citationsDOIOpen Access PDF

Abstract

BACKGROUND: As of April 23, 2021, more than 145 million cases and almost 3.07 million related deaths were noted because of the coronavirus (Covid-19) Pandemic. Considering the low rate vaccination, the alternative that divided opinions for a long time is an old medicine called hydroxychloroquine. MAIN BODY: The aim of this review was to synthesize the different highlights of the most important studies published since the beginning of the epidemic crisis. After a precise study of the available bibliography dealing with this subject and the addition of an adapted example, which is the current situation of Algeria, the results showed the effectiveness of the Algerian method as well as the impact that this treatment had. CONCLUSION: We concluded that in brief, given the inexistence of a better solution, we ultimately recommend that patients with severe COVID-19 to be treated for the moment with Hydroxychloroquine combined with Azithromycin in view of its effectiveness, while waiting for another solution.

Topics & Concepts

HydroxychloroquineAzithromycinCoronavirus disease 2019 (COVID-19)PandemicMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakSubject (documents)Intensive care medicineFamily medicineVirologyComputer sciencePathologyLibrary scienceInfectious disease (medical specialty)MicrobiologyDiseaseBiologyOutbreakAntibioticsCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchDiverse Scientific Research Studies